<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30275851</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1738-6756</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>21</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of breast cancer</Title>                <ISOAbbreviation>J Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.</ArticleTitle>            <Pagination>                <MedlinePgn>233-243</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.4048/jbc.2018.21.e41</ELocationID>            <Abstract>                <AbstractText>Breast cancer has the highest incidence among all malignancies diagnosed in women. Therapies have significantly improved over the years due to extensive molecular and clinical research; in a large number of cases, targeted therapies have provided better prognosis. However, one specific subtype remains elusive to targeted therapies-the triple-negative breast cancer. This immunohistochemically defined subtype is resistant to both endocrine and targeted therapies, leading to its poor prognosis. A field that is of great promise in current cancer research is epigenetics. By studying the epigenetic mechanisms underlying tumorigenesis-DNA methylation, histone modifications, and noncoding RNAs-advances in cancer treatment, diagnosis, and prevention are possible. This review aims to synthesize the epigenetic discoveries that have been made related to the triple-negative breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Temian</LastName>                    <ForeName>Daiana Cosmina</ForeName>                    <Initials>DC</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0292-4218</Identifier>                    <AffiliationInfo>                        <Affiliation>Research Center for Functional Genomics, Biomedicine and Translational Medicine, &quot;Iuliu Hatieganu&quot; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Faculty of Medicine, &quot;Iuliu Hatieganu&quot; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pop</LastName>                    <ForeName>Laura Ancuta</ForeName>                    <Initials>LA</Initials>                    <AffiliationInfo>                        <Affiliation>Research Center for Functional Genomics, Biomedicine and Translational Medicine, &quot;Iuliu Hatieganu&quot; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Irimie</LastName>                    <ForeName>Alexandra Iulia</ForeName>                    <Initials>AI</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Dental Propaedeutics, Aesthetic, Department of Prosthetic Dentistry and Dental Materials, &quot;Iuliu Hatieganu&quot; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berindan-Neagoe</LastName>                    <ForeName>Ioana</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Research Center for Functional Genomics, Biomedicine and Translational Medicine, &quot;Iuliu Hatieganu&quot; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>MedFUTURE Research Center for Advanced Medicine, &quot;Iuliu Hatieganu&quot; University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Functional Genomics and Experimental Pathology, The Oncology Institute &quot;Prof. Dr. I Chiricuta&quot;, Cluj-Napoca, Romania.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>20</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>J Breast Cancer</MedlineTA>            <NlmUniqueID>101314183</NlmUniqueID>            <ISSNLinking>1738-6756</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 May 10;7(19):27158-75</RefSource>                <PMID Version="1">27029062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2015 Feb 02;6:5899</RefSource>                <PMID Version="1">25641231</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2016 Mar 15;18(1):33</RefSource>                <PMID Version="1">26975198</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 May 10;6(13):11150-61</RefSource>                <PMID Version="1">25883211</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Oct 30;5(20):9864-76</RefSource>                <PMID Version="1">25296969</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Drug Discov. 2014 May;13(5):337-56</RefSource>                <PMID Version="1">24751816</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogenesis. 2012 Jul 02;1:e17</RefSource>                <PMID Version="1">23552734</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Genet. 2015 Jan 26;6:2</RefSource>                <PMID Version="1">25674102</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2011 Jul;121(7):2750-67</RefSource>                <PMID Version="1">21633166</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2015 Mar 07;17:33</RefSource>                <PMID Version="1">25888415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2018 Jan;68(1):7-30</RefSource>                <PMID Version="1">29313949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2010 Nov 11;363(20):1938-48</RefSource>                <PMID Version="1">21067385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol. 2011 Aug;18(4):161-4</RefSource>                <PMID Version="1">21874112</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Signal. 2016 May;28(5):506-515</RefSource>                <PMID Version="1">26876786</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2011;16 Suppl 1:61-70</RefSource>                <PMID Version="1">21278442</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2013 May 28;108(10):2172-7</RefSource>                <PMID Version="1">23558900</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2013 Oct 1;73(19):5858-68</RefSource>                <PMID Version="1">23801749</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Carcinog. 2015 Dec;54(12):1656-67</RefSource>                <PMID Version="1">25328122</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2007 Feb 23;128(4):683-92</RefSource>                <PMID Version="1">17320506</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Dec 15;137(12):2785-94</RefSource>                <PMID Version="1">25410431</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Med Rep. 2015 Apr;11(4):3155-9</RefSource>                <PMID Version="1">25516208</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Jan;131(2):385-99</RefSource>                <PMID Version="1">21359954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2012 May 21;14(3):R79</RefSource>                <PMID Version="1">22613095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Opin Immunol. 2012 Apr;24(2):207-12</RefSource>                <PMID Version="1">22236695</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hematol Oncol. 2018 Feb 27;11(1):32</RefSource>                <PMID Version="1">29486795</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Genomics. 2018 Feb 20;19(1):150</RefSource>                <PMID Version="1">29458327</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2016 Nov 11;9:6921-6933</RefSource>                <PMID Version="1">27956838</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Mar 15;5(5):1174-84</RefSource>                <PMID Version="1">24632568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2015 Nov 30;16(12):28347-76</RefSource>                <PMID Version="1">26633365</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Top Behav Neurosci. 2014;16:19-48</RefSource>                <PMID Version="1">24318963</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2014 Jan;232(2):142-50</RefSource>                <PMID Version="1">24114677</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2000 Aug 17;406(6797):747-52</RefSource>                <PMID Version="1">10963602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2016 Aug 31;16:700</RefSource>                <PMID Version="1">27581651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 May 1;69(9):3802-9</RefSource>                <PMID Version="1">19366799</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Breast Cancer. 2016 Sep;19(3):223-230</RefSource>                <PMID Version="1">27721871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2018 Feb 9;293(6):2125-2136</RefSource>                <PMID Version="1">29263092</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2018 Apr;38:30-38</RefSource>                <PMID Version="1">29202330</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biochem. 2013 Sep;381(1-2):61-8</RefSource>                <PMID Version="1">23881244</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2015 Aug 13;34(33):4333-46</RefSource>                <PMID Version="1">25417703</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Carcinogenesis. 2014 Oct;35(10):2254-63</RefSource>                <PMID Version="1">24925028</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2012 Jul;181(1):257-67</RefSource>                <PMID Version="1">22626806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Jun 21;7(25):38270-38281</RefSource>                <PMID Version="1">27223259</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2008 Jan 25;7:15</RefSource>                <PMID Version="1">18221536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2015 Mar 20;17:43</RefSource>                <PMID Version="1">25887482</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 31;8(5):7598-7613</RefSource>                <PMID Version="1">27935867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2008;10(3):R46</RefSource>                <PMID Version="1">18485221</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Aug 16;7(33):53997-54009</RefSource>                <PMID Version="1">27283767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2016 May;95(21):e3783</RefSource>                <PMID Version="1">27227949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Rev Mol Med. 2016 Nov 7;18:e18</RefSource>                <PMID Version="1">27817751</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Clin Exp Pathol. 2015 Sep 01;8(9):11076-83</RefSource>                <PMID Version="1">26617826</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2016 Feb;16(2):110-20</RefSource>                <PMID Version="1">26775620</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Jun 16;11(6):e0157368</RefSource>                <PMID Version="1">27310713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jul 12;8(49):85276-85289</RefSource>                <PMID Version="1">29156719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Apr 07;10(4):e0120936</RefSource>                <PMID Version="1">25849487</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2010 Jan;220(2):263-80</RefSource>                <PMID Version="1">19927298</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(3):R36</RefSource>                <PMID Version="1">20565864</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Ther Res. 2014 Mar 19;3(2):1-11</RefSource>                <PMID Version="1">25177489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2014 Oct;147(3):639-51</RefSource>                <PMID Version="1">25224916</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cancer Res. 2015 Jun 15;5(7):2330-43</RefSource>                <PMID Version="1">26328265</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epigenomics. 2018 Jun;10(6):765-783</RefSource>                <PMID Version="1">29480027</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Carcinogenesis. 2015 Sep;36(9):1051-60</RefSource>                <PMID Version="1">26088362</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2015 Aug;14(8):1848-57</RefSource>                <PMID Version="1">26037781</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2016 Jan 21;529(7586):413-417</RefSource>                <PMID Version="1">26735014</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Dec 15;11(12):e0167016</RefSource>                <PMID Version="1">27977696</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2015 Apr 1;21(7):1688-98</RefSource>                <PMID Version="1">25208879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2015 Nov;230(11):2683-94</RefSource>                <PMID Version="1">25808524</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gene. 2018 Jan 30;641:248-258</RefSource>                <PMID Version="1">29038000</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>                <PMID Version="1">23000897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2013 Oct;20(10):3254-8</RefSource>                <PMID Version="1">23975317</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods Mol Biol. 2015;1238:3-25</RefSource>                <PMID Version="1">25421652</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Sep 27;6:33435</RefSource>                <PMID Version="1">27671774</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Dec 12;8(69):114156-114172</RefSource>                <PMID Version="1">29371976</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Aspects Med. 2013 Jul-Aug;34(4):753-64</RefSource>                <PMID Version="1">22906839</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO Mol Med. 2011 May;3(5):279-90</RefSource>                <PMID Version="1">21472990</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Molecules. 2015 Mar 02;20(3):3898-941</RefSource>                <PMID Version="1">25738536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Chromosomes Cancer. 2017 Feb;56(2):147-158</RefSource>                <PMID Version="1">27717206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Jun 09;9(6):e98930</RefSource>                <PMID Version="1">24911873</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Aug 1;8(41):71285-71291</RefSource>                <PMID Version="1">29050361</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2013 Dec;22(6):1026-33</RefSource>                <PMID Version="1">24063766</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Oncol (Dordr). 2015 Dec;38(6):433-42</RefSource>                <PMID Version="1">26392359</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Ther. 2015;16(6):856-65</RefSource>                <PMID Version="1">25996380</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Oct 1;15(19):6148-57</RefSource>                <PMID Version="1">19789319</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 21;8(12):19478-19490</RefSource>                <PMID Version="1">28061448</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Dis. 2010;32(1-2):5-24</RefSource>                <PMID Version="1">21965309</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epigenetics. 2012 Nov;7(11):1225-9</RefSource>                <PMID Version="1">23069641</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Jun 28;7(26):40418-40436</RefSource>                <PMID Version="1">27250026</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>                <PMID Version="1">11553815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2016 Nov 4;291(45):23756-23768</RefSource>                <PMID Version="1">27650498</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Aug 28;6(25):21730-9</RefSource>                <PMID Version="1">26078338</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Oct 10;28(29):e563-4; author reply e565-6</RefSource>                <PMID Version="1">20679605</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):257-70</RefSource>                <PMID Version="1">21818544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Apr 15;464(7291):1071-6</RefSource>                <PMID Version="1">20393566</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2015 Jan 09;6:5987</RefSource>                <PMID Version="1">25574598</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2013 Oct;24 Suppl 6:vi7-23</RefSource>                <PMID Version="1">23970019</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">DNA methylation</Keyword>            <Keyword MajorTopicYN="N">Histone code</Keyword>            <Keyword MajorTopicYN="N">Triple negative breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Untranslated RNA</Keyword>        </KeywordList>        <CoiStatement>CONFLICT OF INTEREST: The authors declare that they have no competing interests.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30275851</ArticleId>            <ArticleId IdType="doi">10.4048/jbc.2018.21.e41</ArticleId>            <ArticleId IdType="pmc">PMC6158152</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>